Citalopram is a selective seratonin reuptake inhibitor available in 10 mg, 20 mg and 40 mg doses. The double blind, randomized, controlled trial included 119 patients assigned to citalopram 20 mg, 60 ...

An 18-year-old female was stable on citalopram according to retrospectively administered MD and anxiety scales. Her internist changed her medication to paroxetine 20 mg because it was "better for ...

Celexa (citalopram) is a prescription drug that’s used to treat depression in adults. This drug can interact with other medications. For example, Celexa can interact with triptans, NSAIDs, and blood ...

The Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial evaluated 284 patients with CAD who had major depression for at least four weeks and Hamilton ...

WASHINGTON, March 30 (UPI) -- Officials at the U.S. Food and Drug Administration are clarifying dosing and warning recommendations for the drug Celexa, or citalopram hydrobromide. "There is the ...

The antidepressant citalopram (Celexa, Forest Laboratories) reduces agitation in older patients with Alzheimer's disease (AD), but at the expense of increased cardiac adverse effects and mildly ...

Up to 75% of women experience hot flashes, which can negatively impact quality of life. As hot flash physiology is not definitively understood, it cannot be assumed that effective agents represent ...

Pretreatment IVELT was measured during a 4-week baseline period, during which patients were requested to experience coitus at least four times. Pretreatment frequency of sexual intercourse was the ...

The possible dose-dependency for the antidepressant effect of selective serotonin reuptake inhibitors (SSRIs) remains controversial. We believe we have conducted the first comprehensive patient-level ...

High doses of the antidepressants citalopram (Celexa) and escitalopram (Cipralex, Lexapro) do not appear to carry greater risk of sudden cardiac death than comparable doses of other selective ...

March 28 (Reuters) - U.S. health regulators added new warnings to the label of Forest Laboratories Inc's antidepressant Celexa and its generic versions about a potential risk of rare heart diseases.